Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-28
1995-06-27
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 723, 435 691, 435 696, 4351723, 4352402, 4352523, 4353201, 514 2, 514 12, 530350, 530385, 536 221, 536 231, 536 235, A61K 3816, C12N 500, C12P 2106, C07H 1900
Patent
active
054280079
ABSTRACT:
Peptides encoded by a substantially pure polynucleotide coding for an alpha and/or beta human globin, the globin when part of a hemoglobin molecule conferring lower oxygen affinity than normal hemoglobin to result in a mutant hemoglobin, the mutant hemoglobin having an oxygen affinity measured for stripped hemoglobin characterized by a P.sub.50 of 30 torr to 3 atmospheres and/or by a Hill coefficient between 2.5 and 1.0. Such mutant hemoglobin being useful to increase tissue oxygenation in a patient, to replace hemoglobin in the bloodstream of a patient and to treat patients suffering from burns.
REFERENCES:
patent: 5028588 (1991-07-01), Hoffman et al.
Brunori et al. "A macromolecular transducer . . . " PNAS 75, 9 4310-4312.
Fischer et al. "Perfluorochemicals . . . " Int. J. Radiation Onc. Biol. Phys. 12 pp. 95-102 1986.
Sidney V. Suggs, et al, "Use of Synthetic Oligonucleotides as Hybridization Probes: Isolation of Cloned cDNA Sequences for Human .sup..beta..sub.2 -microglobulin", Proc. Natl. Acad. Sci. USA, vol. 78, No. 11, pp. 6613-6617, Nov. 1981.
F. Bossa et al, "Primary Structure of Hemoglobins From Trout (Salmo Irideus), Partial Determination of Amino Acid Sequence of HB Trout IV", vol. 64, No. 1, FEBS Letters, Apr. 1976, pp. 76-79.
E. Fioretti et al, "Preparation of Apohemoglobin Trout IV and Reconstitution With Different Hemes", vol. 68, No. 4, 1976, pp. 1169-1173, Biochemical And Biophysical Research Communications.
Richard Earl Dickerson, "Hemoglobin: structure, function, evolution, and pathology", Chapter 4, Abnormal Human Hemoglobins, pp. 148-157, 1983.
Baserga Susan J.
Fischer James J.
Kim Hyosuk
Wax Robert A.
Yale University
LandOfFree
Genetically engineered low oxygen affinity mutants of human hemo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically engineered low oxygen affinity mutants of human hemo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered low oxygen affinity mutants of human hemo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287471